Takeda

Takeda

Verified
Research-based pharmaceutical company

Launch date
Employees
Market cap
JPY5.8t
Net debt
JPY3.8t
Firm valuation
$66.3b (Public information from 2022)
Osaka Osaka Prefecture (HQ)
Corporate Venture Fund: Takeda Ventures

Company information

Edit
Launch date
Employees
Market cap
JPY5.8t
Net debt
JPY3.8t
Firm valuation
$66.3b (Public information from 2022)
Revenues, earnings & profits over time
JPY201620172018201920202021E2022E
Revenues-1.7t1.8t2.1t3.3t3.2t3.4t
% growth--2 %18 %57 %(3 %)8 %
EBITDA-378.7b437.5b477.4b684.1b1.1t1.1t
% EBITDA margin-22 %25 %23 %21 %33 %33 %
Profit-114.9b186.9b109.1b44.2b376.0b227.9b
% profit margin-7 %11 %5 %1 %12 %7 %
EV / revenue-2.8x2.7x5.8x2.9x3.1x2.5x
EV / EBITDA-12.9x10.8x25.3x14.0x9.2x7.6x
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/AIPO
$38mGrant
$19.8mGrant
Total Funding$57.8m

Recent News about Takeda

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Bioniz
ACQUISITION by Equillium Feb 2022
ArmaGen Technologies
ACQUISITION by JCR Pharmaceuticals Mar 2020
Millennium Pharmaceuticals
ACQUISITION by Takeda Apr 2008
Shire
ACQUISITION by Takeda Dec 2018
TiGenix
ACQUISITION by Takeda Jul 2018
Naurex
ACQUISITION by Allergan Jul 2015
View 88 more